Log In
Print this Print this

hRS7-SN-38, sacituzumab govitecan (IMMU-132)

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionHumanized antibody against epithelial glycoprotein-1 (EGP-1) conjugated with SN-38, the active metabolite of irinotecan
Molecular Target Epithelial glycoprotein-1 (EGP-1)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today